Magazine Article | June 1, 2021

Why The DTP Model Is A Win For Drug Manufacturers And Patients

Source: Life Science Leader

By Jay McHarg

Pre-COVID, typically DTP was only a distribution tactic for specialty medicines not generally sold in commercial pharmacies. But similar to telemedicine, once access was greatly diminished, alternatives started to emerge, including curbside pickup and in-town delivery.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: